About the Company:
Philosys is a manufacturer of blood glucose monitoring systems distributed under the Gmate brand name. Philosys places a premium on technological innovation holding multiple patents of automatic coding and smart phone applications. Gmate meters are available both as standalone units and as the first monitor completely integrated with Apple iPhone and Android smart phones. Based in South Korea, Philosys is entering the US market with offices in New York, NY and Jupiter, FL. 855-GO-GMATE
Press Release :
Philosys, Inc. Receives FDA Approval for Gmate® VOICE Blood Glucose Meter
Gmate® VOICE, the speaking meter that looks and feels like a smartphone
NEW YORK, N.Y., March 18, 2013 - Philosys, Inc. announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Gmate® VOICE Blood Glucose Monitoring System. With its sleek modern design and large 2.5” screen, the Gmate® VOICE has the look and feel of a smartphone. “This meter is designed to connect diabetics in many new ways due to its intuitive smartphone-like interface,” says James Winchester, Director of Marketing for Philosys. “We are confident this design advance will become the standard for all new meters,” Mr. Winchester elaborated.
Designed for diabetics, the Gmate® VOICE uses Real Voice Technology to clearly announce blood glucose readings. The Gmate® VOICE also offers the world’s largest memory to keep track of blood glucose levels over time. In the United States, the Gmate® VOICE will be available in English and Spanish (additional languages available for appropriate markets).
Philosys continues to make major advances in diabetic technology with the introduction of the Gmate® SMART Meter. With this new innovative technology, diabetics will be able to obtain their blood sugar levels right from their iPhone, iPad or iPod devices. Gmate® SMART has CE Mark approval and is currently available in Europe, Middle East, Asia, Africa and Latin America.
Philosys continues to move forward in their commitment to providing innovative health solutions to diabetics around the world.
For more information about the Gmate® VOICE and Gmate® SMART blood glucose monitoring systems, please visit www.gmate.com or contact email@example.com.
The New iPhone 5 And Gmate SMART Create a Dynamic Duo in Medical Diagnostics
Gmate® SMART blood glucose meter compatible with new iPhone 5, without need for a costly adapter.
25-September-2012 –Apple has finally revealed the long anticipated iPhone 5 to the world. Philosys, Inc. is pleased to announce: the revelation that the Gmate® SMART meter is the only true Smartphone meter to connect directly to the new iPhone 5, without the need of a costly adapter.
The first in its class and weighing in at less than 2 ounces, the Gmate® SMART is the smallest, most innovative blood glucose meter in the world. The Gmate® SMART connects directly to the headphone jack on the bottom of the iPhone 5. The technology is patent pending and Philosys is the only company to utilize the headphone jack as a power source and data connection point.
With a simple download of the FREE Gmate® SMART app from the iTunes app store, the Gmate® SMART interfaces directly with the iPhone 5’s operating system. No adapter is necessary. The Gmate® SMART also supports the prior versions of iPhone as well as the iPod touch and iPad.
The Gmate® SMART has received CE Mark approval and is available in Europe. Philosys is currently in negotiations with other partners for global distribution and international telecommunication contracts. Gmate® SMART is pending FDA approval and will be available soon for purchase in the United States.
Philosys, Inc. is an industry leader in the development and manufacture of innovative medical diagnostic instruments.
For more information please visit www.gmate.com or call us at 1.855.GO.GMATE.
Philosys Awarded CE Mark for new Gmate® SMART meter and seeks global telecommunications partners
Gmate® SMART, the world’s smallest blood glucose meter
New York, NY August 13, 2012. - Philosys announced today that it has received the CE Mark for the Gmate® SMART Blood Glucose Monitoring System. According to Jonathan Johnson, Director of Regulatory Affairs, “CE designation will allow Philosys to market the Gmate® SMART within the European Union (EU), consisting of the 27 EU Member States. Moreover, the CE mark signifies that the product has been assessed before being placed on the market and meets European Union safety, health and environmental protection requirements.” Gmate® SMART is the first of its kind blood glucose monitor to work with the iPhone, iPad and iPod devices. The CE Mark approval is an important milestone for Philosys in offering innovative technology to diabetics around the globe. Planning for the European market has been underway for more than a year and diabetic patients in the EU should be able to begin using the Gmate® SMART before the end of 2012.
“With the launch of the Gmate® SMART in Europe, Philosys provides the perfect solution to diabetics looking for new technology to help monitor blood glucose levels in an active, fast paced lifestyle,” said Jennifer Kupar, Manager of Operations at Philosys. “As smart phone usage continues to increase in Europe, there is a growing demand for this breakthrough patent-pending technology that Philosys can deliver.” Kupar continued.
As a next step, Philosys is pursuing global telecommunications contracts for the Gmate® SMART. Philosys is seeking to partner with major cell phone providers in a variety of markets to provide innovative health solutions to diabetic patients and health systems.
The Gmate® SMART is the smallest, most innovative glucose meter in the world. The patent pending technology of the Gmate® SMART uses the operating system of the smart phone and works by plugging the device into the headphone connector of the smart phone, and launching the companion app.
Philosys, Inc. anticipates FDA Approval for New Gmate® Blood Glucose Monitoring System
The world’s smallest blood glucose meter is expected to be available to U.S. diabetics in the third quarter of 2012.
New York, NY, August 1, 2012 – Philosys announced today that it has applied for approval from the U.S. Food and Drug Administration (FDA) for its Gmate® blood glucose monitoring system in Q4 2011, and expects approval in third quarter 2012. The new Gmate ® SMART is the smallest and most innovative meter in the world. It’s Smartphone technology is patent pending, and is the world’s only blood glucose meter to work with the headphone connector of the iPhone, iPad, and iPod.
“We are very excited to be close to FDA approval for our blood glucose monitoring technology and are preparing to bring this capability to the United States,” said Jennifer Kupar, Operations Manager for Philosys. “Gmate® SMART is the World's first smartphone meter that uses the headphone connector for the iPhone, iPad and iPod. Given the dramatic rise of diabetes in the US and more tech savvy consumers, there is a growing demand for this medical technology that Philosys can meet.”
Diabetic technology in the U.S. has not kept pace with the digital explosion of smartphones, tablets, and other digital devises. The US Centers for Disease Control predicts that as many as 1 in 3 U.S. adults could have diabetes by 2050. This increase could bring the average incidence of diabetes to more than 30 percent of the population.
“More and more U.S. consumers with diabetes are purchasing Smartphones daily,” Kupar continued. “Gmate® is the perfect solution for diabetics seeking digital solutions to monitor their disease with the push of a button. We look forward to FDA approval of our revolutionary device this year.”
The GmateTM blood glucose monitoring system is diabetic technology that makes life simple for consumers. GmateTM SMART is the smallest and most innovative meter in the world and works with the iPhone. For more information, visit http://www.gmate.com.
Philosys is a manufacturing company that specializes in medical, diagnostic and analytical instruments. The range of services provided covers the entire product cycle from concept through to manufacture. Philosys’s philosophy is to develop cost-effective design and manufacturing solutions that satisfy our customer’s vision.